Malaria trial yield vaccines finance model
Next month, hundreds of African infants will get an experimental vaccine against malaria in a medial trial that could foster a multibillion dollar collaboration of science, philanthropy and market
Next month, hundreds of African infants will get an experimental vaccine against malaria in a medial trial that could foster a multibillion dollar collaboration of science, philanthropy and market